Head-to-head · WeighScore
MDLive vs Remi Meds
The verdict
MDLive takes it — 58.8/100 to 48.4/100.
MDLive grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MDLive (an Evernorth/Cigna company) is a large telehealth provider offering urgent care, primary care, dermatology and behavioral health.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | MDLive | Remi Meds |
|---|---|---|
| WeighScore | 58.8/100 | 48.4/100 |
| Grade | C | C |
| Scorecard rank | #358 | #493 |
| Semaglutide | Not disclosed | $249/mo (0.25 mg dose, compounded) |
| Tirzepatide | Not disclosed | $349/mo (2.25 mg dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #358 · C
Strengths
- Prescribes FDA-approved branded GLP-1s including Wegovy and Zepbound
- Covered through insurance and employer benefits for 50M-plus people
- Board-certified physicians averaging about 15 years of experience
- Part of Evernorth/Cigna, a large established healthcare organization
- Offers full primary care, not just a single weight-loss funnel
Where it loses points
- GLP-1s only at clinician discretion in a Primary Care routine visit
- Anti-obesity meds not available in FL, LA, MS or NJ
- Distributed mainly via insurers and employers; cost varies by plan
- No transparent published monthly cash price for GLP-1 care
Graded #493 · C
Strengths
- Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers
- LegitScript verification badge on the homepage
- Publishes 503A FDCA compliance language on the tirzepatide page
- Per-dose-tier pricing fully shown — no 'as low as' floor-only obfuscation
- Operating corporate entity disclosed (T-C Health Co)
Where it loses points
- No named medical director, founder, or physician on any public page
- States served not listed — 'nationwide' claim with no per-state detail
- Clinical care runs through Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 companies (Remi Meds itself not FDA-warned)
- Year founded and corporate history are opaque
- Two phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.